Michel Sáenz Farret

Investigaciones académicas y publicaciones

• Sáenz- Farret M, et al. Diabetes in Subarachnoid Hemorrhage. Rev Invest Clin 2012, 64 (6):596-603
• Part II
• F Micheli, A Pellene, D Arcushin, A Calzinari, M Sáenz-Farret. Pet Killing as a Manifestation of
• Impulse Control Disorder Secondary to Pramipexol. Clinical neuropharmacology 03/2015;
• 38(2):55-56.
• M Sáenz-Farret et al. Primary Central Nervous System Lymphoma as a cause of Hemichorea in a
• patient with acquired immunodeficiency syndrome: a case report and a review of the literature.
• Basal Ganglia 03/2015.
• Sandoval-Rincón M, Sáenz-Farret M, Miguel-Puga A, Micheli F, Arias-Carrión O. Rational
• pharmacological approaches for cognitive dysfunction and depression in Parkinson’s disease.
• Frontiers in Neurology 03/2015; 6:71
• Farret MS, Cersosimo MG, Ramirez Gomez CC, Micheli F. Clinicoradiological comparisons between
• vascular parkinsonism and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2015 Jun 10. pii:
• jnnp-2015-311155.
• Michel SF, Oscar AC, Correa TE, Alejandro PL, Micheli F. Pisa Syndrome. Clin
• Neuropharmacol. 2015 Jul-Aug;38 (4):135-40.
• Pellene A, Saenz-Farret M, Micheli F. Recurrent and Alternating Pisa Syndrome. Clin
• Neuropharmacol. 2015 Nov-Dec;38(6):252-4.
• Perandones C, Farini VL , Pellene LA , Sáenz Farret M, Cuevas SM, Micheli FE. and Radrizzani M.
• Parkinson’s Disease in a Patient with 22q11.2 Deletion Syndrome: The Relevance of Detecting
• Mosaicisms by Means of Cell-By-Cell Evaluation Techniques. Single Cell Biol 4: 123.
• doi:10.4172/2168-9431.1000123
• Saenz-Farret M, Ramirez-Gomez CC, Araoz-Olivos N, Carrillo-Canedo H, Aldinio V, MontillaUzcategui VG, Kauffman M, Micheli F. Gerstmann-Sträussler-Scheinker syndrome in an
• Argentinean family due to mutationat codon 117 of the Prion Protein Gene (PrPA117V). J Neurol
• Sci. 2016 May 15;364:50-2.
• Montilla Uzcátegui V, Araujo Unda H, Daza Restrepo A, Sáenz Farret M, Micheli F. Paroxysmal
• Nonkinesigenic Dyskinesias Responsive to Carbamazepine in Fahr Syndrome: A Case Report. Clin
• Neuropharmacol. 2016 Jun 7. [Epub ahead of print]
• Sáenz Farret Michel, Zúñiga C, Montilla Uzcátegui V, Ramírez Gómez Carolina, Micheli Federico.
• Neuropsychiatric symptoms and premanifest Huntington’s Disease. Movement Disorders. June
• 2016
• Sáenz-Farret M, Pellene A, Micheli F. Recurrent and Alternating Pisa Syndrome: A Surprising
• Entity. Clin Neuropharmacol. 2016 Nov/Dec;39(6):337
• Micheli F, Uribe-Roca C, Saenz-Farret M. Alcohol-Sensitive Generalized Dystonia. Clin
• Neuropharmacol. 2017 Jan/Feb;40(1):48-49
• Sáenz-Farret M, Sandoval-Rodríguez V, Paz-Navarro CE, Zúñiga-Ramírez C. Successful Treatment of
• Brachial Plexopathy Due to Herpes Zoster Infection With Intravenous Immunoglobulin. Clin
• Neuropharmacol. 2017 Jan/Feb;40(1):43-47
• Ramírez Gómez CC, Serrano Dueñas M, Bernal O, Araoz N, Sáenz Farret M, Aldinio V, Montilla V,
• Micheli F. A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients
• With Parkinson Disease. Clin Neuropharmacol. 2017 Mar/Apr; 40(2):51-55.
• Appiani F, Miranda M, Ramírez CZ, Farret MS, Borges V, et al. (2017) A proposal for a semantic
• change in the current diagnostic criteria of Parkinson's disease Psychosis. Open J Parkinsons Dis
• Treatm 1(1): 030-031. Clinical Group
• Sandoval-Rodríguez V, Cansino-Torres MA, Sáenz-Farret M, Castañeda-Cisneros G, Moreno G,
• Zúñiga-Ramírez C. Autosomal dominant leukodystrophy presenting as Alzheimer's-type dementia.
• Mult Scler Relat Disord. 2017 Oct; 17:230-233
• Cansino-Torres MA, Sandoval-Rodríguez V, Sáenz-Farret M, Zúñiga-Ramírez C. Allergy to
• Carbidopa. Clin Neuropharmacol. 2018 Feb 9.
• González-Usigli HA, Perez-Torres T, Saenz-Farret M, Rivero-Moragrega P. Superficial siderosis
• misdiagnosed as idiopathic bilateral neurosensorial deafness. BMJ Case Rep. 2018 Jul 11; 2018.
• Zúñiga-Ramírez C, de Oliveira LM, Kramis-Hollands M, Algarni M, Soto-Escageda A, Sáenz-Farret
• M, González-Usigli HA, Fasano A. Beyond dystonia and ataxia: Expanding the phenotype of
• SQSTM1 mutations. Parkinsonism Relat Disord 2019
• Sáenz-Farret M, Cansino-Torres MA, Sandoval-Rodríguez V, Navarro-Ibarra R, Zúñiga-Ramírez C.
• The Spectrum of Acute Disseminated Encephalomyelitis and Mild Encephalopathy with Reversible
• Splenial Lesion. Case Rep Neurol Med. 2019 Oct 17;2019:9272074.
• Zúñiga-Ramírez C, Kramis-Hollands M, Mercado-Pimentel R, González-Usigli HA, Sáenz-Farret M,
• Soto-Escageda A, Fasano A.. Generalized Dystonia and Paroxysmal Dystonic Attacks due to a Novel
• ATP1A3 Variant. Tremor and other hyperkinetic movements. Tremor Other Hyperkinet Mov (N Y).
• 2019 Dec 13;9.
• Sáenz-Farret M, Munhoz RP, Fasano A, Zúñiga-Ramírez C. TNR Gene Mutation in Familial
• Parkinson's Disease: Possible Implications for Essential Tremor. J Mov Disord. 2020 Dec 7.
• Kleiner G, Fernandez HH, Chou KL, Fasano A, Duque KR, Hengartner D, Law A, Margolius A, Poon
• YY, Sáenz Farret M, Saleh P, Vizcarra JA, Stebbins GT, Espay AJ; PSG NoMoFA Study Group. NonMotor Fluctuations in Parkinson's Disease: Validation of the Non-Motor Fluctuation Assessment
• Questionnaire. Mov Disord. 2021 Jun;36(6):1392-1400.
• Sáenz-Farret M, Loh A, Boutet A, Germann J, Elias GJB, Kalia SK, Chen R, Lozano AM, Fasano A.
• Theta Burst Deep Brain Stimulation in Movement Disorders. Mov Disord Clin Pract. 2021 Jan
• 11;8(2):282-285.
• Sáenz-Farret M, Zúñiga-Ramírez C. Aripiprazole in Meige Syndrome: Clinical Response and
• Implications for Treatment Development. Clin Neuropharmacol. 2021 Aug 26.
• Sasikumar S, Cohn M, Harmsen IE, Loh A, Cho SS, Sáenz-Farret M, Maciel R, Soh D, Boutet A,
• Germann J, Elias G, Youm A, Duncan K, Rowland NC, Strafella AP, Kalia SK, Lozano AM, Fasano A.
• Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition.
• Mov Disord. 2021 Nov 22.
• Castro GS, Aguilar-Alvarado CM, Zúñiga-Ramírez C, Sáenz-Farret M, Otero-Cerdeira E, SerranoDueñas M, González-Usigli HA, Bernal O, Leal-Ortega R, Estrada-Bellmann I, Meléndez-Flores JD,
• Miranda-Cabezas M, Martínez-Hernández HR, Giugni JC, Mejía-Rojas KK, Mori N, Raina GB, García
• Fernández CL, Pecci C, Álvarez-Villalobos NA, Micheli F. Adherence to treatment in Parkinson's
• disease: A multicenter exploratory study with patients from six Latin American countries.
• Parkinsonism Relat Disord. 2021 Dec;93:1-7.
• Sáenz-Farret M, et al. SPG7 and movement disorders: beyond the spastic paraplegia. (Publicado
• en línea en Movement Disorders Clinical Practice).
• Sáenz-Farret M, Tijssen MAJ, Eliashiv D, Fisher RS, Sethi K, Fasano A. Antiseizure Drugs and
• Movement Disorders. CNS Drugs. 2022 Aug;36(8):859-876. doi: 10.1007/s40263-022-
• 00937-x. Epub 2022 Jul 21. PMID: 35861924..
• Sáenz-Farret M, Salinas-Martínez AM, Zúñiga-Ramírez C, Amorín-Costábile I, Maiola R,
• Mejía-Rojas KK, Galeano MS, Velázquez C, Ruiz G, Micheli F. Yerbamate Tea Consumption:
• A Protective Factor in Parkinson Disease. Clin Neuropharmacol. 2022 Jul-Aug 01;45(4):79-
• 83. doi: 10.1097/WNF.0000000000000513. Epub 2022 Jun 24. PMID: 35849689
• Sáenz-Farret, Michel & Micheli, Federico & Dressler, Dirk & Altenmüller, Eckart & K. Krauss,
• Joachim. (2018). Treatment of Dystonia. 268-271. Publisher: Cambridge University Press.
• DOI: https://doi.org/10.1017/9781316459324.054
• Michel Sáenz Farret, Carlos Zúñiga Ramírez, Federico Eduardo Micheli. Manifestaciones
• Neurológicas de las Enfermedades Sistémicas. (2018). Edition: 3a. Publisher: Panamericana. ISBN:
• 9789500696067
• Sáenz-Farret Michel, Alicia Dorantes Cuéllar (2016). Endocrinología Clínica de Dorantes y
• Martínez. Edition 5a. Publisher: Manual Moderno. ISBN: 9786074485554
• Michel Sáenz-Farret (2015). Medicina de Urgencias: clasificaciones, cuadros y fórmulas. Edition 1a.
• Publisher: Manual Moderno.